You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Maryland Prescription Drug Monitoring Program
Maryland Prescription Drug Monitoring Program
Currently selected
Section Menu
Maryland Prescription Drug Monitoring Program
PDMP Home
Academic Detailing
Advisory Board
Clinical Resources
Contact
Dispenser Reporting - RX Gov
Forms
Health Care Providers and Delegates
Interstate Data Sharing
Investigative Users
Law and Regulations
Currently selected
Mandated Use FAQs
OCSA Continuing Education Requirement
PDMP FAQs
Recent Updates
Registration FAQs
Technical Advisory Committee
Use Mandate Information
Left_Content
PDMP Law and Regulations
Main_Content
Statute
The PDMP is governed by Maryland state statute within the
Health-General Article, Section 21-2a
.
Statutory changes made annually during General Session, to the original authorizing legislation are found below:
2020
HB 663 (Chapter 290)
2019
HB 25 (Chapter 531)
,
HB 466 (Chapter 364)
2018
HB 517 (Chapter 772)
2017
SB 38 (Chapter 40)
2016
HB 437 (Chapter 147)
2015
SB 757 (Chapter 381)
2014
HB 255 (Chapter 92), HB 1296 (Chapter 651)
2013
SB 80 (Chapter 177)
2012
SB 603 (Chapter 267)
2011
SB 883 (Chapter 166)
Regulations
The Notice of Final Action for the PDMP regulations was published in the Maryland Register in December, 2012. The regulations have been adopted by the Secretary as
COMAR 10.47.07.
Center_Content
